Table 2.
Neonatal outcomes have been laid out by associated CGM findings, strongest predictors (AUROC), and their corresponding time points. Only the highest AUROCs were shown as the strongest predictors.
| Outcome | CGM metrics | Time points |
|---|---|---|
| LGA | TIR, TAR, SD | All |
| Mean glucose | 24 and 34 weeks | |
| Neonatal hypoglycemia | Mean glucose, TIR, TAR | 24 and 34 weeks |
| TAR | First trimester | |
| NICU admission | Mean glucose, TIR, TAR, SD | 24 weeks |
| TIR | First trimester | |
| No CGM metric associations | 34 weeks | |
| Outcome | Strongest predictors (AUROC) | Time points |
| LGA | 1, 5-AG, TIR (0.64) | First trimester |
| TIR, fructosamine, HbA1c (0.64) | 24 weeks | |
| TAR (0.67) | 34 weeks | |
| Neonatal hypoglycemia | gCD59 (0.61) | First trimester |
| gCD59 (0.72) | 24 weeks | |
| HbA1c (0.68) | 34 weeks | |
| NICU admission | gCD59 (0.73) | 24 weeks |
| HbA1c (0.66) | 34 weeks | |
| Preeclampsia | Mean CGM glucose (0.65) | First trimester |
| Mean CGM glucose (0.72) | 24 weeks | |
| Fructosamine (0.76) | 34 weeks | |
| Preterm birth | Mean CGM glucose, TAR (0.61) | First trimester |
| Mean CGM glucose, TAR, gCD59 (0.64) | 24 weeks | |
| HbA1c (0.65) | 34 weeks |
This work is licensed under a